Nine-months FY2026 Earnings Report

January 30, 2026

Company name: PEGASUS CO., LTD. Listing: Tokyo Stock Exchange Securities code: 6262

URL: https://www.pegasus.co.jp

Representative: Shigemi Mima Representative Director

Inquiries: Masakazu Tada Executive Officer Telephone: +81-6(6451)1351

Scheduled date to commence dividend payments: -

Preparation of supplementary material on financial results: Yes Holding of financial results briefing: None

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the nine months ended December 31, 2025 (from April 1, 2025 to December 31, 2025)
   1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      	Net sales		Operating profit		Ordinary profit		Profit attributable to owners of parent
      Nine months ended December 31, 2025 December 31, 2024	Millions of yen 16,507 16,031	% 3.0 23.2	Millions of yen 893 1,274	% (29.9) -	Millions of yen 1,046 1,436	% (27.2) 330.1	Millions of yen 628 990	% (36.5) -

      Note: Comprehensive income	For the nine months ended December 31, 2025:	¥	(266) million [	-%]
      	For the nine months ended December 31, 2024:	¥	702 million [	(74.6) %]

      	Basic earnings per share	Diluted earnings per share
      Nine months ended	Yen	Yen
      December 31, 2025	25.50	-
      December 31, 2024	39.90	-

   2. Consolidated financial position

   	Total assets	Net assets	Equity-to-asset ratio
   As of December 31, 2025 March 31, 2025	Millions of yen 43,677 46,391	Millions of yen 31,989 33,637	% 70.7 70.0

   Reference: Equity

   As of December 31, 2025:	¥	30,895 million
   As of March 31, 2025:	¥	32,477 million

2. Cash dividends

   	Annual dividends per share
   	First quarter-end	Second quarter-end	Third quarter-end	Fiscal year-end	Total
   	Yen	Yen	Yen	Yen	Yen
   Fiscal year ended March 31, 2025	-	5.00	-	8.00	13.00
   Fiscal year ending March 31, 2026	-	10.00	-
   Fiscal year ending March 31, 2026 (Forecast)				20.00	30.00

   Note: Revisions to the forecast of cash dividends most recently announced: Yes

3. Consolidated financial result forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)

(Percentages indicate year-on-year changes.)

(Note) 1 Revisions to the financial result forecast most recently announced: Yes

2 At the Board of Directors meeting held on October 31, 2025, PEGASUS CO., LTD. (PEGASUS) resolved to acquire treasury stock. The impact of this acquisition has been taken into account in the consolidated earnings forecast for "net income per share".

1. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None

2. Changes in accounting policies, changes in accounting estimates, and restatement

   1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

   2. Changes in accounting policies due to other reasons: None

   3. Changes in accounting estimates: None

   4. Restatement: None

3. Number of issued shares (common shares)

   1. Total number of issued shares at the end of the period (including treasury shares)

      As of December 31, 2025	24,828,600 shares
      As of March 31, 2025	24,828,600 shares

   2. Number of treasury shares at the end of the period

      As of December 31, 2025	887,076 shares
      As of March 31, 2025	17,976 shares

   3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

• Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None

• Proper use of earnings forecasts, and other special matters

Statements contained in this summary regarding PEGASUS' plans, strategies, and expectations for future performance, which are based on information available to PEGASUS at the time of writing.

They are therefore subject to a number of uncertainties and unknowable factors, and actual results may thus differ substantially from those projected.

Quarterly Consolidated Financial Statements and Primary Notes Quarterly Consolidated Balance Sheet

(Thousands of yen)

As of March 31, 2025

As of December 31, 2025

Assets

Valuation difference on available-for-sale securities

(190,550)

(62,597)

As of March 31, 2025

As of December 31, 2025

Accumulated other comprehensive income

Foreign currency translation adjustment

8,314,959

7,276,940

Total accumulated other comprehensive income

8,363,571

7,423,760

Total net assets

33,637,431

31,989,730

Total liabilities and net assets 46,391,590 43,677,434

Non-controlling interests 1,159,906 1,094,228

Remeasurements of defined benefit plans 239,161 209,418

(Thousands of yen)

Quarterly Consolidated Statements of Income and Comprehensive Income